Top Markets
#1 DogBull DogBull +54.65%
#2 Siren Siren +31.05%
#3 OriginTrail OriginTrail +17.89%
#4 Purr Purr +12.64%
#5 Yield Basis Yield Basis +11.36%
#6 龙虾 (Lobster) 龙虾 (Lobster) +10.15%
#7 Stargate Finance Stargate Finance +8.65%
#8 Cysic Cysic +8.61%
#9 COTI COTI +7.71%
#10 MetYa MetYa +7.40%
Coin of the day
DogBull DogBull
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Acrivon Therapeutics, Inc. Common Stock Acrivon Therapeutics, Inc. Common Stock

Acrivon Therapeutics, Inc. Common Stock

ACRV
Classificação em ações #22054
Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company primarily focused on creating oncology treatments. The firm employs a unique strategy to identify patients whose tumors are predicted to be sensitive to specific medications, utilizing its proprietary proteomics-based platform for patient identification. This advanced system, named Acrivon Predictive Precision Proteomics (AP3), serves as a precision medicine tool. It is instrumental in developing drug-specific OncoSignature companion diagnostics, which are designed to pinpoint individuals most likely to benefit from the company's therapeutic candidates. Acrivon's flagship clinical asset is ACR-368, a selective small molecule inhibitor that targets both CHK1 and CHK2. This candidate is currently undergoing a potentially pivotal Phase 2 trial for a range of advanced tumor types, notably including platinum-resistant ovarian, endometrial, and bladder cancers. Beyond its lead program, the company is also cultivating several early-stage pipeline programs. These initiatives concentrate on crucial regulatory points within the DNA damage response and cell cycle regulation pathways, specifically identifying targets such as the protein kinases WEE1 and PKMYT1. Established in 2018, Acrivon Therapeutics, Inc. maintains its headquarters in Watertown, Massachusetts.
Preço da ação
$2.23
Última sincronização: 2026-08-21
Valor de mercado
$95.23M
Variação (1 dia)
1.14%
Variação (1 ano)
63.60%
País
US
Negociar Acrivon Therapeutics, Inc. Common Stock (ACRV)

Categoria

Healthcare
Histórico de preços das ações de Acrivon Therapeutics, Inc. Common Stock (ACRV)
Preço de fecho mais alto: $1.94 em 2026-08-01

Preço de fecho mais baixo: $13.89 em 2022-11-01
Histórico de preços das ações da Acrivon Therapeutics, Inc. Common Stock de 2022 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -23.66%
2025 -63.95%
2024 34.00%
2023 -58.79%
2022 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH